ClinicalTrials.govpublic full text
Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission
leukemia, acute myeloid leukemia, aml, high-risk myelodysplastic syndrome, mds, ixazomib, mln9708, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 994058
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.